Wednesday, 16 Oct 2019

TNF inhibitor

Date Typesort descending Title Save
13 Dec 2016 News Supreme Court Declines Biosimilar Patent Dispute
27 Jul 2017 News Biosimilar Pricing Wars Have Begun
26 Sep 2016 News FDA Approves New Amgen Biosimilar for Adalimumab
24 Mar 2016 News First Head-to-Head TNF Trial Ends in a Draw
31 Jan 2017 News Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor?
24 Apr 2017 News FDA Approves Renflexis as Second Infliximab Biosimilar
22 May 2015 News Amgen & Abbvie Increase the Price of TNF Inhibitors
27 Jul 2016 News Long-Term Safety of Adalimumab Reviewed
11 Jun 2018 News Risk of Psoriasis Complicating TNF Inhibitor Therapy
05 Dec 2016 News Key Lessons from the TNF Inhibitor Head-to-Head EXXELERATE Study
30 May 2017 News Golimumab Fails in Polyarticular Juvenile Arthritis
25 Jan 2018 News Anti-Drug Antibodies Partly Explain Secondary TNF Inhibitor Failures
29 Mar 2019 News FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis
17 May 2015 News Adalimumab Gets FDA Orphan Drug Status for Use in Hidradenitis Suppurativa
28 Aug 2017 News Another Adalimumab Biosimilar Approved
13 Jul 2016 News FDA Arthritis Advisory Committee Recommends Approval of Adalimumab Biosimilar
05 Mar 2018 News Severe Stevens-Johnson and Toxic Epidermal Necrolysis Syndromes May Respond to Etanercept
17 May 2017 News Inflammatory Arthritis Stable after Switch to Biosimilar Infliximab
18 Jun 2015 News Frequency of Infliximab Infusion Reactions
14 Sep 2015 News Adalimumab FDA Approved for Hidradenitis Suppurativa